Research Site

Lenexa, Kansas 66219

3 studies enrolling now · 15 studies all time

What they study most

Asthma, Autosomal Dominant Polycystic Kidney Disease, Breast Neoplasms, COPD, Carcinoma, Chronic Obstructive Pulmonary Disease, Healthy, Heart Failure, Influenza A, Metastases, Migraine, Moderate to Very Severe COPD

Studies at this site

• Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin — Recruiting now
• Safety, Tolerability and Pharmacokinetics of AZD1613 in Adults With Autosomal Dominant Polycystic Kidney Disease — Recruiting now
• A Study to Characterize the Safety and Immunogenicity of AZD6489 in Participants 60 Years of Age and Older (ARIES) — Recruiting now
• A Phase I/II Study on Safety AND Immunogenicity of AZD4117 and AZD5315 Vaccines (PANDA) — Running, not enrolling
• Study to Evaluate the Efficacy and Safety of Erenumab (AMG 334) Compared to Placebo in Migraine Prevention — Completed
• Evaluate the Effect of Aclidinium Bromide on Long-term Cardiovascular Safety and Exacerbations in Moderate to Very Severe COPD Patients. — Completed
• A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg — Completed
• Efficacy and Safety Study of Benralizumab in Adults and Adolescents Inadequately Controlled on Inhaled Corticosteroid Plus Long-acting β2 Agonist — Completed
• A First-in-Human, Double Blind, Single Dose Study in Healthy Subjects and Subjects With Mild Atopic Asthma. — Completed
• JC Virus Antibody Study of Participants With Relapsing Forms of MS Receiving Treatment With Natalizumab — Completed
• Effectiveness of DMF and Its Impact on PROs in Suboptimal GA Responders With RMS — Completed
• Iressa Expanded Access Program (EAP) — Completed
• A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease — Completed
• A Study in Healthy Volunteers to Evaluate Serum and Urine Levels of the Investigational Product Versus Comparator. — Completed
• The CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer — Stopped early